Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer Feeling Frisky
Investopedia
Thursday, February 4, 2010 - 3:24pm
tags:
Pfizer
US FDA asks for $4bn for 2011
In-Pharma Technologist
Thursday, February 4, 2010 - 10:43am
tags:
FDA
Dems writing compromise healthcare bill
Fierce Pharma
Thursday, February 4, 2010 - 10:41am
tags:
healthcare reform, healthcare bill
Is Novartis shopping its Roche stake?
Fierce Pharma
Thursday, February 4, 2010 - 10:40am
tags:
Novartis, Roche
Pfizer’s China Strategy: ‘Feet On the Street,’ ‘Key Opinion Leaders’
WSJ Online
Thursday, February 4, 2010 - 10:39am
tags:
Pfizer, China
FTC Wants More Staff To Tackle Biopharma Mergers
Pharmalot
Thursday, February 4, 2010 - 10:34am
tags:
FTC, M&A
Achillion Pharma Out-Licensed China Rights for HIV, Hepatitis Treatment
Seeking Alpha
Thursday, February 4, 2010 - 10:32am
tags:
HIV, hepatitis B, Achillion, China
Cell Therapeutics Options Show Record Bets on Drugmaker Retreat
Bloomberg
Thursday, February 4, 2010 - 10:30am
tags:
Cell Therapeutics, options
10 Biotech Stocks on Clinical Trials Watch
TheStreet.com
Thursday, February 4, 2010 - 10:26am
tags:
Vertex Pharmaceuticals, Optimer, Novelos Therapeutics, Medivation, Isis Pharmaceuticals, Genzyme, GenVec, Delcath, Amgen, Allos, Affymax
Bristol-Myers Squibb Is Freezing Salaries
Pharmalot
Thursday, February 4, 2010 - 9:51am
tags:
Bristol-Myers Squibb
Dr. Reddy’s Finance Chief Says No Plan to Sell Shares to Glaxo
Bloomberg
Thursday, February 4, 2010 - 9:49am
tags:
Dr Reddy's, GSK
Glaxo to Stop Pain Research, Start Rare-Disease Unit
Bloomberg
Thursday, February 4, 2010 - 9:48am
tags:
GSK
Allergan 4Q profit grows 51 percent as sales climb
Yahoo/AP
Thursday, February 4, 2010 - 9:48am
tags:
earnings, Allergan
Alkermes Testing Schizophrenia Drug
TheStreet.com
Thursday, February 4, 2010 - 9:46am
tags:
schizophrenia, Alkermes, aripiprazole, Abilify, Bristol-Myers Squibb
GlaxoSmithKline 4th quarter profit up 66 pct with strong boost from swine flu vaccine
Yahoo/AP
Thursday, February 4, 2010 - 9:45am
tags:
GSK, earnings
Pfizer's New Alzheimer's Drug: A Black Box Indeed
Seeking Alpha
Thursday, February 4, 2010 - 9:44am
tags:
Pfizer, black box, Alzheimer's disease, dimebon
Eli Lilly and GlaxoSmithKline: A Tale of Two Different Pharmas
Seeking Alpha
Wednesday, February 3, 2010 - 9:09pm
tags:
Eli Lilly, GSK
Pfizer Drags Down Pharma
Forbes
Wednesday, February 3, 2010 - 9:04pm
tags:
Pfizer, drug stocks
Medicis gets FDA nod for pain, wrinkle treatment
Yahoo/AP
Wednesday, February 3, 2010 - 4:13pm
tags:
painkillers, wrinkle treatments, Medicis
Keryx Biopharma, FDA agree on design of late-stage trial for drug against colorectal cancer
Yahoo/AP
Wednesday, February 3, 2010 - 4:08pm
tags:
colorectal cancer, FDA, clinical trials, Keryx, perifosine

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.